AS
AUPH icon

Altshuler Shaham’s Aurinia Pharmaceuticals AUPH Stock Holding History

Altshuler Shaham’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21K Buy
284
+9
+3% +$132 ﹤0.01% 302
2025
Q4 		$4.39K Buy
+275
New +$3.9K ﹤0.01% 284
2021
Q3 		– Sell
-559,412
Closed -$7.25M – 518
2021
Q2 		$7.25M Buy
559,412
+523,412
+1,454% +$6.67M 0.05% 91
2021
Q1 		$467K Buy
+36,000
New +$522K ﹤0.01% 128

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Altshuler Shaham's AUPH Position: Q1 2026 in Review

Altshuler Shaham increased its Aurinia Pharmaceuticals (AUPH) stake by 3.3% in Q1 2026, buying an estimated $132 and bringing the position to 284 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #302.

Altshuler Shaham first reported a position in AUPH in Q1 2021 and has held it in 4 quarters since. The position peaked at $7.25M in Q2 2021. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Altshuler Shaham held 284 shares of Aurinia Pharmaceuticals worth $4.21K as of Q1 2026.
  • Altshuler Shaham bought 9 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $132.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Altshuler Shaham's portfolio in Q1 2026, its #302 holding.
  • Altshuler Shaham first reported a position in Aurinia Pharmaceuticals in Q1 2021 and has held it in 4 quarters since.
  • Altshuler Shaham's Aurinia Pharmaceuticals position peaked at $7.25M in Q2 2021.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Altshuler Shaham's 13F filing for Q1 2026, filed 18 May 2026.